Description: Most of our standard risk management processes are designed to work well within a shifting environment that stays fundamentally the same over time. We are likely to experience something drastically different starting soon - a major regime change. This webinar addresses how we might react to such turbulent times both to survive current issues and prepare to thrive in a new future. Participants will learn how scenario planning can be used to help envision a way forward. A case study will look at the ways that this regime change might affect our cities, how that could affect insurers and how both cities and insurers can approach the transition period as well as plotting a course for the future regime.

Description: In the U.S., public pension plans vary dramatically in size, complexity, funding position and more. The discussion will start by going over the current status of public plans within the U.S. You will then quickly dive into case studies on two systems, the South Dakota Retirement System and the Wisconsin Retirement System. Both systems use variable benefits or risk sharing measures to control contributions and achieve long term sustainability in a purposeful and stable fashion. During this webcast, you will learn about: The funding approach Historic success Future perspectives of the two retirement systems

Description: "Hear AM Best rating analysts discuss the rating process and the best capital adequacy ratio (BCAR), a quantitative foundation for AM Best’s assessment of carriers’ financial strength. The benchmarking of BCAR scores for various company types (national MCOs, BCBS plans, smaller regional plans) will be discussed. Look at how changes in investment and underwriting environment impacted the results over the past several years. Further, AM Best’s view of the quality of capital and various factors impacting the overall assessment of the balance sheet strength will be discussed. By attending this session, you will: Gain an understanding of AM Best’s building block approach to ratings and how the BCAR results fit into the process. Learn the differences between RBC and BCAR models. Learn how various factors—e.g. liquidity, financial flexibility, financial leverage, the org structure—impact the final AM Best assessment of health companies' capital."

Description: Focus on how innovative health care organizations develop their value proposition for their intended buyers. Presenters will share information about their specific solution and the methods used to derive credible savings estimates, ROI, and performance guarantees. Learn about data utilized, the methods deployed, advantages, disadvantages, and buyers' reaction. This session is expected to be technical, highly informative, and interactive with audience members.

Description: As more gene and cell therapies enter the market at increasingly higher price points, they are ushering in a new era of medicine for rare diseases. Unlike most traditional therapies, gene and cell therapies typically have a short or one-time treatment administration and are anticipated to provide long-term clinical benefits. Actuaries must be prepared to assess, manage, and/or mitigate the risks associated with these therapies. This session includes three different perspectives—a regional plan, a stop loss/reinsurance carrier, and a health care consultant.

Description: Join us in this webinar where we explore the intricate relationship between Professional Employer Organizations (PEOs) and insurance, diving into the art of risk management within this industry. Gain a comprehensive understanding of the diverse insurance products offered by PEOs, the positioning of PEOs in the actuarial landscape, and the strategic navigation of regulatory challenges.

Description: Learn how modernization of data, models, and technology are influencing workflows. This webcast will address how workflows are changing in response to new regulatory requirements and the impacts the changes have on modeling and end-to-end future state operating models. Industry leading actuaries will discuss: How team collaboration can increase quality and speed of reporting to internal and external stakeholders How to strengthen controls and compliance frameworks across finance and actuarial departments How to modernize actuarial input/output for strategic analysis and insights How to attract and retain top talent by improving opportunities for actuaries There will also be dedicated time to ask questions of those who have made the transition.

Description: Join us for the Recent Trends in the Competitive Landscape webcast where you'll find an exploration of the how the insurance industry is rapidly evolving. Discover various structures and reinsurance strategies that will improve a competitive position in the insurance landscape. Come learn about the latest structures used by insurers in the market, which will focus on asset strategies that create a growing segment of the Life and Annuity insurer landscape. Indicate the key components of asset strategies that result in significant changes to the insurance investment landscape.

Description: As the size of the life reinsurance market in Bermuda has grown to over half a trillion dollars at the end of 2021, more and more actuaries are getting involved with this 21 square mile North Atlantic island in one way or the other. Come explore a fundamental understanding of the Bermuda solvency framework and an overview of its upcoming changes.

Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.